Thorsten Thormann is Vice President of Research in LEO Pharma, a function that builds and maintains a strong R&D project pipeline. Thorsten has over 20 years of experience within biomedicine and drug research and he and his team has over the past years brought a number of molecules from research and into clinical testing. This has resulted in two marketed products and several of programs currently in clinical development. Prior to being Vice President of Research, Thorsten has over the years held a number of leadership positions within LEO Pharma aiming to build translational drug discovery platforms in dermatology as well as refocusing the early formulation and CMC to build a platform for product improvements based on usability and patient driven innovation. Additionally Thorsten is currently responsible for building the LEO Pharma’s pipeline and organizational unit within rare skin diseases. Thorsten Thormann has a scientific background with a MSc in Chemistry and a PhD in Protein Biology.